HK1168635A1 - A collection and methods for its use - Google Patents
A collection and methods for its useInfo
- Publication number
- HK1168635A1 HK1168635A1 HK12109457.3A HK12109457A HK1168635A1 HK 1168635 A1 HK1168635 A1 HK 1168635A1 HK 12109457 A HK12109457 A HK 12109457A HK 1168635 A1 HK1168635 A1 HK 1168635A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- collection
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18235009P | 2009-05-29 | 2009-05-29 | |
EP09162724 | 2009-06-15 | ||
US29940110P | 2010-01-29 | 2010-01-29 | |
PCT/EP2010/057507 WO2010136598A1 (en) | 2009-05-29 | 2010-05-29 | A collection and methods for its use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1168635A1 true HK1168635A1 (en) | 2013-01-04 |
Family
ID=41210731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12109457.3A HK1168635A1 (en) | 2009-05-29 | 2012-09-25 | A collection and methods for its use |
Country Status (18)
Country | Link |
---|---|
US (3) | US8685896B2 (xx) |
EP (1) | EP2435568B1 (xx) |
JP (1) | JP5804521B2 (xx) |
KR (1) | KR101805202B1 (xx) |
CN (1) | CN102449149B (xx) |
AU (1) | AU2010252939B2 (xx) |
CA (1) | CA2758356C (xx) |
DK (1) | DK2435568T3 (xx) |
ES (1) | ES2511051T3 (xx) |
HK (1) | HK1168635A1 (xx) |
IL (1) | IL216536B (xx) |
MX (1) | MX2011012696A (xx) |
NZ (1) | NZ596603A (xx) |
PT (1) | PT2435568E (xx) |
RU (1) | RU2569187C2 (xx) |
SG (1) | SG175407A1 (xx) |
WO (1) | WO2010136598A1 (xx) |
ZA (1) | ZA201107652B (xx) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
JP5804521B2 (ja) | 2009-05-29 | 2015-11-04 | モルフォシス・アー・ゲー | コレクション及びその使用方法 |
US10143186B2 (en) | 2010-02-08 | 2018-12-04 | Regeneron Pharmaceuticals, Inc. | Common light chain mouse |
US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
US20120021409A1 (en) * | 2010-02-08 | 2012-01-26 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
CA2816558C (en) | 2010-11-19 | 2020-12-29 | Morphosys Ag | A collection and methods for its use |
DK2698431T3 (da) | 2011-03-30 | 2020-11-30 | Chugai Pharmaceutical Co Ltd | Opretholdelse af antigen-bindende molekyler i blodplasma og fremgangsmåde til modifikation af immunogenicitet |
CN117026386A (zh) * | 2011-04-28 | 2023-11-10 | 小利兰斯坦福大学托管委员会 | 与样品相关的多核苷酸的鉴定 |
CN103797029B (zh) | 2011-05-17 | 2016-08-17 | 洛克菲勒大学 | 人类免疫缺陷病毒中和抗体及其使用方法 |
PT3572517T (pt) | 2011-08-05 | 2021-06-23 | Regeneron Pharma | Murganhos da cadeia leve universal humanizada |
ES2682254T3 (es) * | 2011-08-18 | 2018-09-19 | Affinity Biosciences Pty Ltd | Polipéptidos solubles |
CA2791109C (en) | 2011-09-26 | 2021-02-16 | Merus B.V. | Generation of binding molecules |
CN110680920A (zh) | 2011-09-30 | 2020-01-14 | 中外制药株式会社 | 诱导针对靶抗原的免疫应答的抗原结合分子 |
WO2013047748A1 (ja) | 2011-09-30 | 2013-04-04 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
EP3778889A1 (en) | 2011-09-30 | 2021-02-17 | Chugai Seiyaku Kabushiki Kaisha | Ion concentration-dependent binding molecule library |
WO2013092998A1 (en) * | 2011-12-23 | 2013-06-27 | Innate Pharma | Enzymatic conjugation of antibodies |
RS57414B1 (sr) | 2012-03-16 | 2018-09-28 | Regeneron Pharma | Antitela sa lakim lancem konstruisanim sa histidinom i genetički modifikovani glodari za generisanje istih |
BR112014022855A2 (pt) | 2012-03-16 | 2017-07-18 | Regeneron Pharma | animal não humano geneticamente modificado, mamífero geneticamente modificado, e, método para fabricar um animal não humano |
US10132799B2 (en) | 2012-07-13 | 2018-11-20 | Innate Pharma | Screening of conjugated antibodies |
WO2014072482A1 (en) | 2012-11-09 | 2014-05-15 | Innate Pharma | Recognition tags for tgase-mediated conjugation |
CA2901385A1 (en) * | 2013-02-20 | 2014-08-28 | Affinity Biosciences Pty Ltd | Cytoplasmic expression of fab proteins |
US10611824B2 (en) | 2013-03-15 | 2020-04-07 | Innate Pharma | Solid phase TGase-mediated conjugation of antibodies |
EP3010547B1 (en) | 2013-06-20 | 2021-04-21 | Innate Pharma | Enzymatic conjugation of polypeptides |
KR20160042871A (ko) | 2013-06-21 | 2016-04-20 | 이나뜨 파르마, 에스.아. | 폴리펩티드의 효소적 콘쥬게이션 |
SG10201710737VA (en) * | 2013-06-24 | 2018-01-30 | Neximmune | Compositions and methods for immunotherapy |
US20150011405A1 (en) * | 2013-07-03 | 2015-01-08 | Atreca, Inc. | Use of Nanoexpression to Interrogate Antigen Repertoires |
CN106255410B (zh) | 2014-03-21 | 2020-01-10 | 瑞泽恩制药公司 | 产生单结构域结合蛋白的非人动物 |
CA2979702A1 (en) | 2015-03-19 | 2016-09-22 | Regeneron Pharmaceuticals, Inc. | Non-human animals that select for light chain variable regions that bind antigen |
JP2018526034A (ja) * | 2015-09-10 | 2018-09-13 | アフィジェン・インコーポレイテッド | 腫瘍治療薬の配列決定により導かれる選択 |
CA3069047A1 (en) | 2017-07-12 | 2019-01-17 | Nouscom Ag | A universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (msi) cancers |
IL291896A (en) * | 2019-10-03 | 2022-06-01 | Janssen Biotech Inc | Methods for the production of biopharmaceuticals with increased stability through sequence optimization |
CN115362254A (zh) * | 2020-03-27 | 2022-11-18 | 泷搌(上海)生物科技有限公司 | 抗原特异性结合多肽基因展示载体的构建方法与应用 |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
AU616411B2 (en) | 1987-05-14 | 1991-10-31 | Commonwealth Scientific And Industrial Research Organisation | Whey protein fractions |
ATE243754T1 (de) | 1987-05-21 | 2003-07-15 | Micromet Ag | Multifunktionelle proteine mit vorbestimmter zielsetzung |
US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
US5258498A (en) | 1987-05-21 | 1993-11-02 | Creative Biomolecules, Inc. | Polypeptide linkers for production of biosynthetic proteins |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
EP1892296A1 (en) | 1988-09-02 | 2008-02-27 | Dyax Corporation | Generation and selection of recombinant varied binding proteins |
WO1990005144A1 (en) | 1988-11-11 | 1990-05-17 | Medical Research Council | Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
CA2016841C (en) | 1989-05-16 | 1999-09-21 | William D. Huse | A method for producing polymers having a preselected activity |
US6291159B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
US6291160B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
AU652539B2 (en) | 1989-05-16 | 1994-09-01 | Medical Research Council | Co-expression of heteromeric receptors |
US6291161B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
CA2016842A1 (en) | 1989-05-16 | 1990-11-16 | Richard A. Lerner | Method for tapping the immunological repertoire |
US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
WO1991010737A1 (en) | 1990-01-11 | 1991-07-25 | Molecular Affinities Corporation | Production of antibodies using gene libraries |
US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
DE4002897A1 (de) | 1990-02-01 | 1991-08-08 | Behringwerke Ag | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
AU1457992A (en) | 1991-03-01 | 1992-10-06 | Stratagene | Pcr generated dicistronic dna molecules for producing antibodies |
JP4146512B2 (ja) | 1991-03-01 | 2008-09-10 | ダイアックス コープ. | 小型タンパク質 |
DE69228247T2 (de) | 1991-08-10 | 1999-07-08 | Medical Res Council | Behandlung von Zellpopulationen |
US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
EP0605522B1 (en) | 1991-09-23 | 1999-06-23 | Medical Research Council | Methods for the production of humanized antibodies |
WO1993011236A1 (en) | 1991-12-02 | 1993-06-10 | Medical Research Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
US5395750A (en) | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
EP0656941B1 (en) | 1992-03-24 | 2005-06-01 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
US5855885A (en) | 1993-01-22 | 1999-01-05 | Smith; Rodger | Isolation and production of catalytic antibodies using phage technology |
EP0725838A4 (en) | 1993-10-26 | 1997-02-26 | United Biomedical Inc | STRUCTURED SYNTHETIC ANTIGAN BANKS AS DIAGNOSTICS, VACCINE AND THERAPEUTIC AGENTS |
US20010049107A1 (en) | 1994-01-31 | 2001-12-06 | Boston University | Polyclonal antibody libraries |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
EP0873363B1 (en) | 1995-06-14 | 2010-10-06 | The Regents of The University of California | High affinity human antibodies to tumor antigens |
US6696248B1 (en) | 1995-08-18 | 2004-02-24 | Morphosys Ag | Protein/(poly)peptide libraries |
AU725609C (en) | 1995-08-18 | 2002-01-03 | Morphosys Ag | Protein/(poly)peptide libraries |
GB9603507D0 (en) | 1996-02-20 | 1996-04-17 | Isis Innovation | Antibody variants |
JP2002501721A (ja) | 1997-08-01 | 2002-01-22 | モルフォシス・アクチェンゲゼルシャフト | 多量体(ポリ)ペプチドコンプレックスのメンバーをコードする核酸配列を同定するための新規方法およびファージ |
GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
ES2243240T3 (es) | 1999-03-01 | 2005-12-01 | Genentech, Inc. | Anticuerpos para la terapia y diagnostico del cancer. |
ATE417925T1 (de) | 1999-07-20 | 2009-01-15 | Morphosys Ag | Verfahren zur präsentation von (poly)peptiden/proteinen auf bakteriophagenpartikeln via disulfidbindungen |
IL136459A0 (en) | 2000-05-30 | 2001-06-14 | Galim Galil Immunology Ltd | Antibody library |
US7117096B2 (en) | 2001-04-17 | 2006-10-03 | Abmaxis, Inc. | Structure-based selection and affinity maturation of antibody library |
EP2093286B1 (en) | 2001-10-01 | 2013-02-27 | Dyax Corporation | Multi-chain eukaryotic display vectors and uses thereof |
GB0130267D0 (en) | 2001-12-19 | 2002-02-06 | Neutec Pharma Plc | Focussed antibody technology |
JP4323317B2 (ja) | 2001-12-21 | 2009-09-02 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー(ヴェーイーベー・ヴェーゼットウェー) | 可変領域配列のクローニング方法 |
US7244592B2 (en) | 2002-03-07 | 2007-07-17 | Dyax Corp. | Ligand screening and discovery |
CA2505849C (en) | 2002-07-30 | 2013-11-05 | Morphosys Ip Gmbh | Novel tricistronic vectors and uses therefor |
US8557743B2 (en) | 2002-09-05 | 2013-10-15 | Dyax Corp. | Display library process |
GB0309126D0 (en) | 2003-04-17 | 2003-05-28 | Neutec Pharma Plc | Clostridium difficile focussed antibodies |
WO2005023993A2 (en) | 2003-09-09 | 2005-03-17 | Integrigen, Inc. | Methods and compositions for generation of germline human antibody genes |
TWI333977B (en) | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
NZ577824A (en) | 2003-11-12 | 2010-10-29 | Patrys Ltd | Methods of identifying neoplasm-specific antibodies and uses thereof |
US20080003566A1 (en) | 2004-01-26 | 2008-01-03 | David Vaux | Molecular Analysis |
WO2005116645A2 (de) | 2004-05-26 | 2005-12-08 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Isolation allergen-spezifischer immunoglobulin-gene aus humanen b-zellen von atopikern |
JP5143551B2 (ja) * | 2004-07-06 | 2013-02-13 | バイオレン,インク. | ユニバーサル抗体のライブラリー |
US7977050B2 (en) | 2004-09-02 | 2011-07-12 | Bioarray Solutions, Ltd. | Nucleic acid amplification with integrated multiplex detection |
US20060078898A1 (en) | 2004-10-12 | 2006-04-13 | Curry Bo U | Methods and compositions for reducing label variation in array-based comparative genome hybridization assays II |
JP4829609B2 (ja) | 2004-12-22 | 2011-12-07 | 独立行政法人科学技術振興機構 | ヒト抗体酵素およびその生産方法 |
US8551920B2 (en) | 2005-02-01 | 2013-10-08 | Morpho Sys AG | Libraries and methods for isolating antibodies |
WO2007056441A2 (en) | 2005-11-07 | 2007-05-18 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
CN101389655B (zh) | 2005-12-20 | 2013-05-22 | 莫佛塞斯公司 | 新的hcdr3区域集合及其应用 |
EP2021795A4 (en) | 2006-05-04 | 2009-05-13 | Abmaxis Inc | CROSS SPECIES AND MULTI-SPECIAL PRESENTATION SYSTEMS |
EP2190987B1 (en) | 2007-08-21 | 2012-11-14 | MorphoSys AG | Methods for the formation of disulphide bonds |
CA2697193C (en) | 2007-09-14 | 2017-06-06 | Adimab, Inc. | Rationally designed, synthetic antibody libraries and uses therefor |
AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
EP2088432A1 (en) | 2008-02-11 | 2009-08-12 | MorphoSys AG | Methods for identification of an antibody or a target |
US9873957B2 (en) | 2008-03-13 | 2018-01-23 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
EP2100970B1 (en) | 2008-03-13 | 2017-05-10 | National Institute of Immunology | Ig genes specific oligonucleotides and uses thereof |
CA2736277C (en) | 2008-09-10 | 2016-06-21 | Philochem Ag | Display library for antibody selection |
US9403904B2 (en) | 2008-11-07 | 2016-08-02 | Fabrus, Inc. | Anti-DLL4 antibodies and uses thereof |
WO2010130824A2 (en) | 2009-05-15 | 2010-11-18 | Morphosys Ag | Collections and uses thereof |
JP5804521B2 (ja) | 2009-05-29 | 2015-11-04 | モルフォシス・アー・ゲー | コレクション及びその使用方法 |
EP2528944B1 (en) | 2010-01-29 | 2015-08-12 | MorphoSys AG | Rodent combinatorial antibody libraries |
-
2010
- 2010-05-29 JP JP2012512407A patent/JP5804521B2/ja active Active
- 2010-05-29 EP EP10722101.2A patent/EP2435568B1/en active Active
- 2010-05-29 WO PCT/EP2010/057507 patent/WO2010136598A1/en active Application Filing
- 2010-05-29 CA CA2758356A patent/CA2758356C/en active Active
- 2010-05-29 DK DK10722101.2T patent/DK2435568T3/da active
- 2010-05-29 CN CN201080022793.7A patent/CN102449149B/zh active Active
- 2010-05-29 PT PT107221012T patent/PT2435568E/pt unknown
- 2010-05-29 SG SG2011079761A patent/SG175407A1/en unknown
- 2010-05-29 NZ NZ596603A patent/NZ596603A/xx not_active IP Right Cessation
- 2010-05-29 ES ES10722101.2T patent/ES2511051T3/es active Active
- 2010-05-29 MX MX2011012696A patent/MX2011012696A/es active IP Right Grant
- 2010-05-29 RU RU2011147741/10A patent/RU2569187C2/ru active
- 2010-05-29 KR KR1020117031164A patent/KR101805202B1/ko active IP Right Grant
- 2010-05-29 US US13/321,564 patent/US8685896B2/en active Active
- 2010-05-29 AU AU2010252939A patent/AU2010252939B2/en active Active
-
2011
- 2011-10-19 ZA ZA2011/07652A patent/ZA201107652B/en unknown
- 2011-11-22 IL IL216536A patent/IL216536B/en active IP Right Grant
-
2012
- 2012-09-25 HK HK12109457.3A patent/HK1168635A1/xx unknown
-
2014
- 2014-01-31 US US14/169,162 patent/US9624293B2/en active Active
-
2017
- 2017-03-03 US US15/449,561 patent/US10647757B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2010136598A1 (en) | 2010-12-02 |
JP2012527881A (ja) | 2012-11-12 |
AU2010252939A1 (en) | 2011-10-13 |
IL216536B (en) | 2018-06-28 |
US9624293B2 (en) | 2017-04-18 |
KR20120087809A (ko) | 2012-08-07 |
MX2011012696A (es) | 2012-03-29 |
US20170218048A1 (en) | 2017-08-03 |
US8685896B2 (en) | 2014-04-01 |
EP2435568A1 (en) | 2012-04-04 |
KR101805202B1 (ko) | 2017-12-07 |
NZ596603A (en) | 2013-07-26 |
CA2758356A1 (en) | 2010-12-02 |
CN102449149B (zh) | 2014-04-23 |
RU2011147741A (ru) | 2013-07-10 |
PT2435568E (pt) | 2014-10-08 |
SG175407A1 (en) | 2011-11-28 |
DK2435568T3 (da) | 2014-09-08 |
EP2435568B1 (en) | 2014-07-02 |
ZA201107652B (en) | 2012-06-27 |
IL216536A0 (en) | 2012-02-29 |
AU2010252939B2 (en) | 2014-06-26 |
RU2569187C2 (ru) | 2015-11-20 |
US10647757B2 (en) | 2020-05-12 |
ES2511051T3 (es) | 2014-10-22 |
JP5804521B2 (ja) | 2015-11-04 |
US20140163208A1 (en) | 2014-06-12 |
CA2758356C (en) | 2016-07-26 |
CN102449149A (zh) | 2012-05-09 |
US20120077713A1 (en) | 2012-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1168635A1 (en) | A collection and methods for its use | |
GB2474118B (en) | Automated collection point | |
ZA201303566B (en) | A collection and methods for its use | |
ZA201202189B (en) | Blood collection device | |
SG2014014732A (en) | Method for forming a tissue construct and use thereof | |
EP2416657A4 (en) | COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF | |
EP2518476A4 (en) | CANON ASPHERE DETECTION DEVICE | |
PL2475973T3 (pl) | Urządzenie próbkujące | |
EP2430550A4 (en) | BUNDLING OF RELATED OBJECTS AT THE MILL COLLECTION | |
EP2418589A4 (en) | SEARCH DEVICE | |
GB0904631D0 (en) | Oral fluid collection device | |
ZA201201505B (en) | Sample collection device | |
PL2605734T3 (pl) | Urządzenie zbiorcze | |
GB0903471D0 (en) | Data collection device | |
GB2468014B (en) | A grilling device | |
EP2419091A4 (en) | NANOCANAL DEVICE AND RELATED METHODS | |
GB0917149D0 (en) | Impactor containment | |
EP2470022A4 (en) | COMPOUNDS AND METHODS | |
GB2480040B (en) | Dual-purpose grilling device | |
GB0909380D0 (en) | Method and use | |
GB2467764B (en) | Attachment means and methods | |
GB2483410B (en) | Waste collection apparatus | |
GB201007072D0 (en) | A grilling device | |
GB0903348D0 (en) | Compounds and methods relating thereto | |
GB201016148D0 (en) | Collection device |